Ospedale A. Perrino

Futó vizsgálatok

• Fut, nem toboroz

  Appropriate Management of Hepatic EncePhalopaThy AmonG cirrhOtic patieNts Admitted to Internal Medicine

  NCT07727070· Fadoi Foundation, Italy· Forrás

• Toboroz

  Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy

  NCT06994377· European Institute of Oncology· Forrás

• Fut, nem toboroz

  MITO 35a: a multicenter, prospective, single arm trial of Olaparib maintenance therapy in newly diagnosed BRCA wild-type advanced ovarian, fallopian tube and primitive peritoneal cancer

  NCT05233982· 2. fázis· IRCCS Istituto Nazionale Tumori Fondazione Pascale· Forrás

• Toboroz

  Master Framework For Relapse or Refractory Acute Myeloid Leukemia

  NCT06459024· Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS· Forrás

• Toboroz

  Study on the Incidence of Malignant Neoplasms in Patients With Parkinson's Disease and Heterozygous Mutation of the GBA Gene

  NCT06814431· Azienda USL Reggio Emilia - IRCCS· Forrás

• Toboroz

  Study on the Diagnosis and Management of CLL in Italy by GIMEMA

  NCT04867915· Gruppo Italiano Malattie EMatologiche dell'Adulto· Forrás

• Fut, nem toboroz

  CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment Regimen

  NCT05312398· 2. fázis· University of Campania Luigi Vanvitelli· Forrás

• Toboroz

  Phase II randomized trial comparing atezolizumab versus atezolizumab plus bevacizumab as first-line treatment in PD-L1 high advanced non-small-cell lung cancer patients

  2024-517200-10-00· 2. fázis· Fondazione Ricerca Traslazionale· Forrás

• Fut, nem toboroz

  BEVERLY: A randomized open-label phase 3 trial comparing bevacizumab + erlotinib vs erlotinib alone as first line treatment of patients with EGFR mutated advanced non squamous non small cell lung cancer

  NCT02633189· 3. fázis· IRCCS Istituto Nazionale Tumori Fondazione Pascale· Forrás

• Fut, nem toboroz

  A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

  NCT02246621· 3. fázis· Eli Lilly and Company· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Akut mieloid leukémia (AML)1 toboroz
• Áttétes emlőrák1 toboroz
• Gyermekkori daganatok1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Parkinson-kór1 toboroz
• Tüdőrák1 toboroz

Lezárt vizsgálatok

• Lezárult

  EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs

  NCT06316128· Heart Care Foundation· Forrás

• Toboroz

  A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials

  NCT06285318· Janssen-Cilag Ltd.· Forrás

• Lezárult

  Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS

  NCT04810182· Istituto Oncologico Veneto IRCCS· Forrás

• Leállították

  The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir Alafenamide

  NCT03804372· 2. fázis· Gruppo Italiano Malattie EMatologiche dell'Adulto· Forrás